Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v3-EN
Language English English
Date Updated 2018-02-08 2017-12-30
Drug Identification Number 00541869 00541869
Brand name SCOPOLAMINE HYDROBROMIDE INJECTION 0.4MG/ML SCOPOLAMINE HYDROBROMIDE INJECTION 0.4MG/ML
Common or Proper name Scopolamine Scopolamine
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients SCOPOLAMINE HYDROBROMIDE SCOPOLAMINE HYDROBROMIDE
Strength(s) .4MG .4MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10x1mL AMP 10x1mL AMP
ATC code A04AD A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-12-29
Actual start date 2017-12-29
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments